Table 3.
cf-PWV > 10 m/s | Ba-PWV > 1800 cm/s | Carotid hypertrophy | Carotid plaque | ABI < 0.9 | MAU | CKD | |
---|---|---|---|---|---|---|---|
Q1 (7.04 ≤ TyG index < 8.36) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Q2 (8.36 ≤ TyG index < 8.69) | 1.57 (1.24–1.99) | 1.40 (1.13–1.73) | 1.08 (0.68–1.73) | 1.10 (0.88–1.36) | 1.21 (0.88–1.67) | 1.06 (0.86–1.31) | 1.02 (0.76–1.35) |
Q3 (8.69 ≤ TyG index < 9.08) | 1.76 (1.39–2.22) | 1.52 (1.23–1.88) | 1.21 (0.77–1.91) | 1.26 (1.01–1.57) | 1.36 (0.99–1.86) | 1.13 (0.91–1.39) | 1.12 (0.85–1.48) |
Q4 (9.08 ≤ TyG index ≤ 11.63) | 2.48 (1.97–3.13) | 1.76 (1.43–2.18) | 1.27 (0.81–1.99) | 1.12 (0.90–1.39) | 1.77 (1.31–2.40) | 1.7 0(1.27–2.12) | 1.41 (1.07–1.84) |
P for tread | < 0.001 | < 0.001 | 0.26 | 0.17 | < 0.001 | < 0.001 | < 0.01 |
TyG triglyceride glucose, cf-PWV carotid-femoral pulse wave velocity, ba-PWV brachial-ankle pulse wave velocity, ABI ankle–brachial index, MAU microalbuminuria, CKD chronic kidney disease